CTSO (CTSO) Stock Price & Analysis
CTSO (CTSO) rose 3.40% to USD 7.24 as of September 8, 2026 at 15:37 UTC, according to Nexqual real-time market data.
CTSO last closed at USD 7.24; the session ranged USD 6.75–7.44 on volume of 8,553 shares. Market capitalization is —, with a 52-week range of USD 6–20.8 (NCM). Source: Nexqual, September 8, 2026 at 15:37 UTC.
Key Statistics (as of September 8, 2026 at 15:37 UTC)
| Price | USD 7.24 |
|---|---|
| Change | ▲ 3.40% (up) |
| Previous Close | USD 7.24 |
| Open | USD 7.24 |
| Day Range | USD 6.75 – 7.44 |
| 52-Week Range | USD 6 – 20.8 |
| Volume | 8,553 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (CTSO)
Nexqual's technical model rates CTSO "BUY" based on 5 bullish and 3 bearish signals across 93 daily candles, as of September 8, 2026 at 15:37 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 97.92 (overbought) |
| vs SMA50 | Above (USD 0.72) |
| MACD | 0.93 (positive) |
From CTSO's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| APYX | Apyx Medical Corporation | USD 3.01 | ▼ 1.63% |
| AXGN | AxoGen, Inc. | USD 46.38 | ▼ 1.54% |
| CSBR | Champions Oncology, Inc. | USD 5.1 | ▼ 3.41% |
| CUE | Cue Biopharma, Inc. | USD 27.51 | ▼ 0.58% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.59 | ▼ 2.45% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 15:37 UTC. This page is informational and not investment advice.